Crossmark

A randomized, open-label, multicentre, comparative study of therapeutic efficacy, safety, and tolerability of BNO 1030 extract, containing marshmallow root, chamomile flowers, horsetail herb, walnut leaves, yarrow herb, oak bark, dandelion herb, in the treatment of mild forms of COVID-19

Crossref DOI link: https://doi.org/10.1186/s40816-021-00308-x

Published Online: 2021-08-28

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Popovych, Vasyl

Koshel, Ivana

Haman, Yulia

Leschak, Vitaly

Malofiichuk, Oleksandr

Kapustina, Natalia

Shevaga, Ihor

Shevaga, Olha

Kunytska, Tetiana
Funding

Funding for this research was provided by:

Bionorica (2/2020)
License Information

Text and Data Mining valid from 2021-08-28

Version of Record valid from 2021-08-28
More Information

Article History

Received: 12 April 2021

Accepted: 25 July 2021

First Online: 28 August 2021

Declarations

:

: The study was approved by the Ethics Committee of Ivano-Frankivsk National Medical University.

: Not applicable.

: The authors declare that they have no competing interests in this section.

Document is current

Any future updates will be listed below